These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9415878)

  • 1. Minicrash tests biotechnology investors and companies as market fluctuates.
    Dorey E
    Nat Biotechnol; 1997 Dec; 15(13):1333. PubMed ID: 9415878
    [No Abstract]   [Full Text] [Related]  

  • 2. Was PolyMASC's early demise self-inflicted?
    Michael A
    Nat Biotechnol; 1999 Jul; 17(7):633. PubMed ID: 10409347
    [No Abstract]   [Full Text] [Related]  

  • 3. The biotechnology bubble machine.
    Rasnick D
    Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813
    [No Abstract]   [Full Text] [Related]  

  • 4. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 5. Stock market crash threatens start-up biotech companies.
    Lehrman S
    Nature; 1998 Sep; 395(6698):104. PubMed ID: 9744257
    [No Abstract]   [Full Text] [Related]  

  • 6. White biotechnology: ready to partner and invest in.
    Kircher M
    Biotechnol J; 2006; 1(7-8):787-94. PubMed ID: 16897821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will investors return to biotechnology?
    Dorey E
    Nat Biotechnol; 1999 Feb; 17(2):128. PubMed ID: 10052340
    [No Abstract]   [Full Text] [Related]  

  • 8. All together now?
    Nat Biotechnol; 2006 Dec; 24(12):1454. PubMed ID: 17160026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotech-biotech company mergers puzzle investors.
    Dorey E
    Nat Biotechnol; 1998 Jul; 16(7):616. PubMed ID: 9661187
    [No Abstract]   [Full Text] [Related]  

  • 10. Tales of two medical startup companies.
    Bottles K
    Physician Exec; 2001; 27(5):80-2. PubMed ID: 12881911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cures on the cob.
    Roosevelt M
    Time; 2003 May; 161(21):56-7. PubMed ID: 12800326
    [No Abstract]   [Full Text] [Related]  

  • 12. How will biotechnology fare in pharma's big plan?
    Nat Biotechnol; 1996 Nov; 14(11):1515. PubMed ID: 9634811
    [No Abstract]   [Full Text] [Related]  

  • 13. European markets target foreign biotechs.
    Louët S
    Nat Biotechnol; 2003 Jul; 21(7):719. PubMed ID: 12833075
    [No Abstract]   [Full Text] [Related]  

  • 14. Investors remain wary after first quarter downturn.
    Fletcher L
    Nat Biotechnol; 2002 May; 20(5):413-4. PubMed ID: 11981536
    [No Abstract]   [Full Text] [Related]  

  • 15. Can personalized drugs pay off?
    Stipp D
    Fortune; 2002 May; 145(10):168. PubMed ID: 12025349
    [No Abstract]   [Full Text] [Related]  

  • 16. GM giants pair up to do battle.
    Mitchell P
    Nat Biotechnol; 2007 Jul; 25(7):695-6. PubMed ID: 17621277
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotechnology. Indian centre receives funds.
    Jayaraman KS
    Nature; 1992 Jan; 355(6357):192. PubMed ID: 1731207
    [No Abstract]   [Full Text] [Related]  

  • 18. Ownership at too high a price?
    Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotechnology, bioremediation, and blue genes.
    Bialy H
    Nat Biotechnol; 1997 Feb; 15(2):110. PubMed ID: 9035117
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.